Human papilloma virus (HPV) causes cervical and anogenital cancers
Human papilloma virus (HPV) is the causative agent of cervical and anogenital cancers, with the HPV16 strain responsible for up to 60% of all HPV-associated cancers. 1 Little is known about HPV susceptibility to disinfection; this is of concern since in addition to well documented sexual transmission, non-sexual transmission may also be important. Using a novel method of virus production the researchers demonstrate that glutaraldehyde (GTA) and
ortho-phthalaldehyde (OPA), two commonly used disinfectants, are unable to inactivate HPV in a 45 min liquid suspension test.
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Disinfectant efficacy against HPV could not previously be tested
The activity of disinfectants against HPV has not previously been tested due to the lack of a method to produce 
Glutaraldehyde and OPA shown to be completely ineffective against HPV
Of all the clinical disinfectants tested, only 1.2% PAA-silver and 0.525% hypochlorite achieved a >4 log 10 reduction in infectivity after disinfection of native virions. They also achieved this reduction when tested against quasi-virus, as did isopropanol (both concentrations) and phenol. GTA (both concentrations) and OPA were ineffective in producing any significant reduction in infectivity in both virus types. This is of concern -OPA is currently accepted as a high level disinfectant widely used to reprocess semi-critical items including intracavity ultrasound probes and GTA is used as a sterilant in medical and dental healthcare facilities. As a result, the contact times for 3.4% GTA and 0.55% OPA were extended from 45 min to 24 h, which did not result in a decrease in viral infectivity.
The findings suggest that a review of clinical disinfectants and disinfection standards as related to high level disinfection may be warranted.
